MD, MPH
Associate Professor, Medicine-Oncology
UNC-Chapel Hill
Clinical Research
Meet Tracy Rose
Area of Interest
Rose’s clinical interest is treating patients with genitourinary cancers, including bladder, kidney, prostate and testicular cancers. She is interested in the development of novel therapies and combination therapies for patients with urologic malignancies, including the design and implementation of clinical trials. She also studies the molecular alterations that contribute to the development of genitourinary cancers.
Awards and Honors
- Caregivers at Carolina Program Award Recipient, 2019
- Junior Faculty Development Award, 2018
- Bladder Cancer Advocacy Network Young Investigator Award, 2017
News and Stories
Kim, Rose highlight advances in kidney cancer research and care in JAMA
William Kim, MD, and Tracy Rose, MD, MPH, published a review highlighting new scientific insights that have led to advances in kidney cancer treatment and increased survival rates.
Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes
Tracy Rose, MD, MPH, Matthew Milowsky, MD, and colleagues report that the regimen reduced the invasiveness of the cancer in 56% of patients in a phase II clinical trial.
